While Dr Tillett is the right person to respond, he is spot on. You don't attend that conference unless you want to get out of it something, meaning some serious talk with big pharma reps. RAC is NOT ready this year to do that, we need clinical results, the more the merrier to convince big pharma that they should take us seriously and we have scientific proof for that, not empty talk and assumptions and hopes. I would love if we would be in the position, but we are not there. Next year, especially is the stage 1 trial finishes and the results are outstanding, yes, it will make sense. Until then the only thing can happen that one big pharma might be interested to a regional deal. I am just being realistic.
General Comments / Chat, page-11273
-
- There are more pages in this discussion • 627 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.060(3.77%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.53 | $83.43K | 53.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20575 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |